Yttrium 90 Market Research Report 2023-2031 Market Innovative ... - theyyscene.ca
| RAFA Stock | USD 0.06 0.01 8.96% |
About 62% of Rafarma Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Rafarma Pharmaceuticals pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Rafarma Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Rafarma Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Rafarma |
Yttrium 90 Market Research Report 2023-2031 Market Innovative ... theyyscene.ca
Read at news.google.com
 |
Rafarma Pharmaceuticals Fundamental Analysis
We analyze Rafarma Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rafarma Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rafarma Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
Rafarma Pharmaceuticals is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Peers
Trending Equities
Complementary Tools for Rafarma Pink Sheet analysis
When running Rafarma Pharmaceuticals' price analysis, check to measure Rafarma Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rafarma Pharmaceuticals is operating at the current time. Most of Rafarma Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Rafarma Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rafarma Pharmaceuticals' price. Additionally, you may evaluate how the addition of Rafarma Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |